Specifically, while overexpression of ERBB2 had no significant impact on the migration rates of all of the three human prostate cancer cell lines, overexpression of RAS significantly decreased the migration rates of LnCaP and DU145 cell lines. Here, ERBB2 is linked to prostate cancer.